Target intelligence / Profile preview

Heat-labile enterotoxin of enterotoxigenic Escherichia coli (LT)

Target
LT
Molecular classification
AB5 toxin, Enzyme, ADP-ribosyltransferase, Bacterial toxin
01

Overview

Heat-labile enterotoxin (LT) is a potent AB5-type protein toxin produced by enterotoxigenic Escherichia coli (ETEC), a leading cause of traveler's diarrhea and neonatal diarrhea in developing countries (StatPearls, 2023). The toxin consists of a single A-subunit with enzymatic activity and a pentameric B-subunit responsible for binding to GM1 ganglioside receptors on host intestinal cells (UniProt, 2024). Upon internalization, the A-subunit ADP-ribosylates the Gs alpha subunit, causing permanent activation of adenylate cyclase and a subsequent surge in cyclic AMP levels (PubMed, 2022). This signaling cascade triggers the opening of chloride channels, leading to the profuse watery diarrhea characteristic of ETEC infection. Beyond its role in pathogenesis, the B-subunit (LTB) is highly immunogenic and is utilized in vaccine development, such as in the oral vaccine Dukoral, while the whole toxin is frequently studied as a mucosal adjuvant due to its ability to enhance immune responses to co-administered antigens (EMA, 2023; Journal of Immunology, 2021).

Other names
LTE. coli heat-labile enterotoxinLT-ILT-IIHeat-labile enterotoxinLT toxinEnterotoxin LT
02

Mechanism of action

The B-subunit pentamer binds to GM1 ganglioside receptors on the surface of intestinal epithelial cells, facilitating the entry of the A-subunit. Once inside, the A-subunit catalyzes the ADP-ribosylation of the Gs alpha subunit of the heterotrimeric G protein, leading to the constitutive activation of adenylate cyclase. This results in elevated intracellular levels of cyclic AMP (cAMP), which activates protein kinase A and subsequently the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel, causing massive secretion of water and electrolytes into the intestinal lumen.

03

Biological functions

ADP-ribosylationSignal transductionActivation of adenylate cyclaseIon transportMucosal adjuvant
04

Disease associations

InfectionTraveler's diarrheaGastroenteritisCholera-like illness
05

Safety considerations

Severe dehydrationElectrolyte imbalancePotential neurotoxicity with intranasal administration of wild-type toxinAdjuvant-related inflammation
06

Interacting drugs

Dukoral

3 more in the full profile.

07

Biomarkers

Anti-LT IgA antibodiesAnti-LT IgG antibodiesFecal LT toxin levelsLT-specific memory B cells

Beyond the preview

Go deeper on Heat-labile enterotoxin of enterotoxigenic Escherichia coli (LT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heat-labile enterotoxin of enterotoxigenic Escherichia coli (LT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call